Stryker’s performance has been negatively impacted by the new Covid-19 vaiant. During the quarter, considerable increases in the Covid-19 cases led to increased infections and hospitalizations, which necessitated greater hospital bed occupancy, resulting in the postponement of elective surgeries. While their implant businesses struggled, their Mako product technology and capital items across their MedSurg portfolio performed well. The company did manage to deliver decent results from its more em ....
